Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Ulisse Biomed S.p.A.
No Price
Closing Price XMIL 30.04.2026:
0,62 EUR
30.04.2026 12:03
Current Prices from Ulisse Biomed S.p.A.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
BORSA ITALIANA S.P.A.
HLX.MI
EUR
30.04.2026 12:03
0,62 EUR
-0,006 EUR
-0,96 %
Share Float & Liquidity
Free Float99,00 %
Shares Float25,79 M
Shares Outstanding26,05 M
Company Profile for Ulisse Biomed S.p.A. Share
Ulisse Biomed S.p.A., a healthcare biotech company, provides diagnostic platforms and products. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It also provides various tests and reagents for sexually transmitted diseases and HPV for oropharyngeal cancer. In addition, the company's platforms also comprise NanoHybrid, a DNA/PNA based multi-modal biomolecule platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy.
